Clinical Trial: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583849) titled 'A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD' on May 07.

Brief Summary: To evaluate the efficacy and safety of a 12-week administration of HSK39004 inhalation powder in clinical trial participants with COPD

Study Start Date: June 24

Study Type: INTERVENTIONAL

Condition: COPD (Chronic Obstructive Pulmonary Disease)

Intervention: DRUG: HSK39004 Dry Powder Inhaler Simulant

HSK39004 Dry Powder Inhaler Simulants, administered via oral inhalation, 1 tablet each time, twice daily

DRUG: HSK39004 Dry Powder Inhaler-0.75mg

HSK39004 D...